[{"symbol": "BIOT.L", "assetClass": "Equity", "aum": 21367449, "avgVolume": 1346, "cusip": "", "description": "The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.", "domicile": "IE", "etfCompany": "L&G", "expenseRatio": 0.49, "inceptionDate": "2018-01-23", "isin": "IE00BF0H7608", "name": "L&G Pharma Breakthrough UCITS ETF", "nav": 11.2, "navCurrency": "USD", "sectorsList": [{"industry": "Basic Materials", "exposure": 5.89}, {"industry": "Communication Services", "exposure": 0}, {"industry": "Consumer Cyclical", "exposure": 0}, {"industry": "Consumer Defensive", "exposure": 0}, {"industry": "Energy", "exposure": 0}, {"industry": "Financial Services", "exposure": 0}, {"industry": "Healthcare", "exposure": 94.11}, {"industry": "Industrials", "exposure": 0}, {"industry": "Real Estate", "exposure": 0}, {"industry": "Technology", "exposure": 0}, {"industry": "Utilities", "exposure": 0}], "website": "https://fundcentres.landg.com/en/uk/institutional/fund-centre/ETF/Pharma-Breakthrough/", "holdingsCount": 0}]